-
Blog
Massachusetts Biotech Community Calls on Congress to Fix the Small Molecule Penalty
05.22.2023
Given the tremendous focus of MA-based companies and investors, we had an opportunity to pen some thoughts which are shared in the attached letter.
-
Blog
From Bad to Worse on Drug Price Controls
05.18.2023
The life sciences venture capital community has long warned against the adverse consequences government price controls for prescription drugs would...
-
Blog
Incubate Celebrates World IP Day
04.26.2023
In the world of Making Medicine, every day should be World IP Day.
-
Statement
Incubate submits comment to CMS regarding its draft guidance for the Medicare Drug Price Negotiation Program
04.17.2023
Incubate submitted our feedback to the Centers for Medicare & Medicaid Services regarding its draft guidance for the Medicare Drug Price Negotiation Program.
-
Infographic
THE SMALL MOLECULE PENALTY
04.01.2023
-
Statement
In Rejecting “March-In Rights” Petition for Xtandi, NIH Sends a Strong Message in Support of Intellectual Property Protections
03.31.2023
Earlier this week, the National Institutes of Health rejected a petition to initiate “march-in” proceedings.
-
Statement
Incubate Testifies at USITC Hearing
03.31.2023
Executive Director John Stanford testified before the International Trade Organization.
-
Blog
Incubate Takes the Stand: Testifying on Global Importance of IP
03.30.2023
See Incubate's blog post from Executive Director John Stanford on his recent testimony before the International Trade Organization about how weakening Intellectual Property protections will damage the early-stage life science ecosystem.
-
Statement
Life Science Venture Capital Responds to President Biden’s FY24 Budget
03.09.2023
Today, March 9th, 2023, President Biden released his Fiscal Year (FY) 2024 proposed budget and recommendations. Notably, one proposal indicates that the President seeks to expand price controls established in the Inflation Reduction Act of 2022.
-
Article
Congress must fix the IRA’s small molecule penalty
03.06.2023
"But the IRA is changing the calculus in a meaningful — and harmful — way."
-
Statement
Life Science Venture Capital Responds to President Biden’s State of the Union
02.08.2023
We must bolster the scientific biopharmaceutical ecosystem, not abandon it.
Resources
